Astrana Health Shares Fall After GlassHouse Research Publishes Short-Seller Report

MT Newswires Live
09/17

Astrana Health (ASTH) shares fell 2% in Thursday trading after short seller GlassHouse Research published a report alleging that the company's profitability depends on its management's subjective estimates.

GlassHouse said the company's reported growth depends on a "continuous, debt-funded" acquisition pipeline, and that the growth story "nearly disappears" without acquisitions.

GlassHouse criticized the company's acquisition of Prospect Health, claiming the deal "created a spring-loading setup, not a reserve overstatement already proven."

"Even insiders struggled to explain the Prospect deal, and the bench is turning over," the report said.

Astrana Health did not immediately respond to MT Newswires' request for comment.

Price: 36.95, Change: -0.75, Percent Change: -1.99

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10